[1] |
LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong.
One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212.
|
[2] |
WANG Guohua, LI Xiaolei, LIU Xiping, DONG Yizhi, ZANG Chen, XU Hong, TIAN Jixiang, ZHAO Jing.
Aerosol inhalation of Tanreqing injection in the treatment of chronic obstructive pulmonary disease: a Meta-analysis
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 544-552.
|
[3] |
BAO Lei, GENG Zihan, GUO Shanshan, YAO Rongmei, SUN Jing, CUI Xiaolan.
Effect of Reyanning Heji on animal models of respiratory infectious inflammation
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 241-247.
|
[4] |
WANG Dan, WU Chen, REN Jingtian.
Risk analysis of dextromethorphan abuse
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(10): 1097-1099.
|
[5] |
ZHU Na, KAN Xiaohong, WU Xinli, DING Haihua, XUE Shuya, ZHANG Yunling.
113 reports of adverse drug reactions induced by fluoroquinolones in patients with tuberculosis
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(4): 404-407.
|
[6] |
SU Xinxin, LI Lixun, WANG Zhifei, XIE Yanming, WANG Qi.
Real-world study on Xiyanping injection combined in the treatment of childhood pneumonia
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(1): 47-51.
|
[7] |
ZHANG Tingyu, GE Ziruo, QIAN Fang, SONG Meihua, LI Xingang, TIAN Di, XU Yanli, CHEN Zhihai, ZHANG Wei.
Clinical Effect of Continuous High-dose Convalescent Plasma Therapy for Rapidly Progressing COVID-19
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(9): 801-805.
|
[8] |
WANG Yaxin, CUI Xiaolan, GUO Shanshan.
Research Progress on Prevention and Treatment of Respiratory Virus Infectious Diseases with Traditional Chinese Medicine
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(6): 592-596.
|
[9] |
SUN Jing, GAO Yingjie, GUO Shanshan, ZHAO Ronghua, SONG Taifa, LI Linmei, YAO Rongmei, CUI Xiaolan, LI Xiaolu, SHI Yujing.
Effect of Qingre Sanjie Capsules on Model of Bacterial Respiratory Tract Infections
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(8): 449-454.
|
[10] |
LUO Hui-li, HUANG Hai-ying, MAI Hui-juan .
Research on Lung protection effects of Ambroxol in Children with Tetralogy of Fallot after Operation
[J]. Chinese Journal of Pharmacovigilance, 2015, 12(9): 528-530.
|
[11] |
.
[J]. Chinese Journal of Pharmacovigilance, 2015, 12(2): 124-124.
|
[12] |
ZHANG Wei,ZHANG Mei-xiang,TAN Lu,WANG Qu,WANG Shu-ping.
Meta-analysis of Adverse Reactions of Bromhexine
[J]. Chinese Journal of Pharmacovigilance, 2015, 12(1): 49-52.
|
[13] |
.
[J]. Chinese Journal of Pharmacovigilance, 2015, 12(1): 58-58.
|
[14] |
HUANG Yuan ,LI Pan-hai ,TIAN Yue-jie.
Analysis of 40 Cases of Adverse Drug Reactions/Event Induced by Ambroxol Hydrochloride Injection
[J]. Chinese Journal of Pharmacovigilance, 2013, 10(3): 163-165.
|
[15] |
JIANG La-Mei, TIAN Yue-jie.
Literation Research on the Incompatibility of Ambroxol Hydrochloride Injection
[J]. Chinese Journal of Pharmacovigilance, 2011, 8(11): 672-674.
|